Table of Contents Author Guidelines Submit a Manuscript
Stem Cells International
Volume 2016 (2016), Article ID 1541823, 16 pages
http://dx.doi.org/10.1155/2016/1541823
Review Article

Emerging Implications for Extracellular Matrix-Based Technologies in Vascularized Composite Allotransplantation

1McGowan Institute for Regenerative Medicine, University of Pittsburgh, Pittsburgh, PA 152192, USA
2School of Medicine, University of Pittsburgh, Pittsburgh, PA 152613, USA
3Department of Bioengineering, University of Pittsburgh, Pittsburgh, PA 152134, USA
4Department of Plastic Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA 152615, USA
5Department of Surgery, University of Pittsburgh, Pittsburgh, PA 15261, USA

Received 15 July 2015; Accepted 5 October 2015

Academic Editor: Pavla Jendelova

Copyright © 2016 Ricardo Londono et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. F. Bodin, C. A. Dissaux, T. Dupret-Bories, T. Schohn, C. Fiquet, and C. Bruant-Rodier, “The transverse musculo-cutaneous gracilis flap for breast reconstruction: how to avoid complications,” Microsurgery, 2015. View at Publisher · View at Google Scholar
  2. E. F. Duraes, G. Schwarz, P. Durand et al., “Complications following abdominal-based free flap breast reconstruction: is a 30 days complication rate representative?” Aesthetic Plastic Surgery, vol. 39, no. 5, pp. 694–699, 2015. View at Publisher · View at Google Scholar
  3. J. W. Swanson, J. L. Johnston, B. T. Mitchell, K. Alcorn, and J. A. Taylor, “Perioperative complications in posterior pharyngeal flap surgery: review of the national surgical quality improvement program pediatric (Nsqip-Peds) database,” The Cleft Palate-Craniofacial Journal, 2015. View at Publisher · View at Google Scholar
  4. J. T. Shores, G. Brandacher, and W. P. A. Lee, “Hand and upper extremity transplantation: an update of outcomes in the worldwide experience,” Plastic and Reconstructive Surgery, vol. 135, no. 2, pp. 351e–360e, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. H. J. Klein, U. Schanz, M. Hivelin et al., “Sensitization and desensitization of burn patients as potential candidates for vascularized composite allotransplantation,” Burns, 2015. View at Publisher · View at Google Scholar
  6. P. Petruzzo, M. Lanzetta, J.-M. Dubernard et al., “The international registry on hand and composite tissue transplantation,” Transplantation, vol. 90, no. 12, pp. 1590–1594, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Siemionow, B. B. Gharb, and A. Rampazzo, “Successes and lessons learned after more than a decade of upper extremity and face transplantation,” Current Opinion in Organ Transplantation, vol. 18, no. 6, pp. 633–639, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. S. Fischer, C. G. Lian, M. Kueckelhaus et al., “Acute rejection in vascularized composite allotransplantation,” Current Opinion in Organ Transplantation, vol. 19, no. 6, pp. 531–544, 2014. View at Publisher · View at Google Scholar
  9. D. A. Leonard, J. M. Kurtz, and C. L. Cetrulo, “Achieving immune tolerance in hand and face transplantation: a realistic prospect?” Immunotherapy, vol. 6, no. 5, pp. 499–502, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Schneeberger, S. Lucchina, M. Lanzetta et al., “Cytomegalovirus-related complications in human hand transplantation,” Transplantation, vol. 80, no. 4, pp. 441–447, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. B. L. Cottrell, G. Perez-Abadia, S. M. Onifer et al., “Neuroregeneration in composite tissue allografts: effect of low-dose FK506 and mycophenolate mofetil immunotherapy,” Plastic and Reconstructive Surgery, vol. 118, no. 3, pp. 615–625, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. V. S. Gorantla and A. J. Demetris, “Acute and chronic rejection in upper extremity transplantation: what have we learned?” Hand Clinics, vol. 27, no. 4, pp. 481–493, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Pomahac, R. M. Gobble, and S. Schneeberger, “Facial and hand allotransplantation,” Cold Spring Harbor Perspectives in Medicine, vol. 4, no. 3, Article ID a015651, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Starzl, G. Brandacher, W. P. A. Lee et al., “Review of the early diagnoses and assessment of rejection in vascularized composite allotransplantation,” Clinical and Developmental Immunology, vol. 2013, Article ID 402980, 9 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. J. T. Schnider, M. Weinstock, J. A. Plock et al., “Site-specific immunosuppression in vascularized composite allotransplantation: prospects and potential,” Clinical and Developmental Immunology, vol. 2013, Article ID 495212, 7 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Folkman and D. M. Long, “The use of silicone rubber as a carrier for prolonged drug therapy,” Journal of Surgical Research, vol. 4, no. 3, pp. 139–142, 1964. View at Publisher · View at Google Scholar · View at Scopus
  17. J. Folkman, D. M. Long Jr., and R. Rosenbaum, “Silicone rubber: a new diffusion property useful for general anesthesia,” Science, vol. 154, no. 3745, pp. 148–149, 1966. View at Publisher · View at Google Scholar · View at Scopus
  18. R. K. Aggarwal, D. C. Ireland, M. A. Azrin, M. D. Ezekowitz, D. P. de Bono, and A. H. Gershlick, “Antithrombotic potential of polymer-coated stents eluting platelet glycoprotein IIb/IIIa receptor antibody,” Circulation, vol. 94, no. 12, pp. 3311–3317, 1996. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Ozaki, A. G. Violaris, and P. W. Serruys, “New stent technologies,” Progress in Cardiovascular Diseases, vol. 39, no. 2, pp. 129–140, 1996. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Fu and Z. Zhuang, “Long-term effects of levonorgestrel-releasing intrauterine system on tamoxifen-treated breast cancer patients: a meta-analysis,” International Journal of Clinical and Experimental Pathology, vol. 7, no. 10, pp. 6419–6429, 2014. View at Google Scholar · View at Scopus
  21. P. A. Royer and K. P. Jones, “Progestins for contraception: modern delivery systems and novel formulations,” Clinical Obstetrics and Gynecology, vol. 57, no. 4, pp. 644–658, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Yasukawa and Y. Ogura, “Medical devices for the treatment of eye diseases,” Handbook of Experimental Pharmacology, vol. 197, pp. 469–489, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Bikram, A. M. Gobin, R. E. Whitmire, and J. L. West, “Temperature-sensitive hydrogels with SiO2-Au nanoshells for controlled drug delivery,” Journal of Controlled Release, vol. 123, no. 3, pp. 219–227, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. H. J. Moon, D. Y. Ko, M. H. Park, M. K. Joo, and B. Jeong, “Temperature-responsive compounds as in situ gelling biomedical materials,” Chemical Society Reviews, vol. 41, no. 14, pp. 4860–4883, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. M. R. Matanović, I. Grabnar, M. Gosenca, and P. A. Grabnar, “Prolonged subcutaneous delivery of low molecular weight heparin based on thermoresponsive hydrogels with chitosan nanocomplexes: design, in vitro evaluation, and cytotoxicity studies,” International Journal of Pharmaceutics, vol. 488, no. 1-2, pp. 127–135, 2015. View at Publisher · View at Google Scholar
  26. X. Sun, H. Gao, G. Wu, Y. Wang, Y. Fan, and J. Ma, “Biodegradable and temperature-responsive polyurethanes for adriamycin delivery,” International Journal of Pharmaceutics, vol. 412, no. 1-2, pp. 52–58, 2011. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Y. Wang, M. C. Liu, and K. A. Kang, “Magnetic nanoparticles and thermally responsive polymer for targeted hyperthermia and sustained anti-cancer drug delivery,” in Oxygen Transport to Tissue XXXIV, vol. 765 of Advances in Experimental Medicine and Biology, pp. 315–321, Springer, New York, NY, USA, 2013. View at Publisher · View at Google Scholar
  28. L. Fu, C. Sun, and L. Yan, “Galactose targeted pH-responsive copolymer conjugated with near infrared fluorescence probe for imaging of intelligent drug delivery,” ACS Applied Materials and Interfaces, vol. 7, no. 3, pp. 2104–2115, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. S. Kumar, R. Acharya, U. Chatterji, and P. De, “Side-chain amino-acid-based ph-responsive self-assembled block copolymers for drug delivery and gene transfer,” Langmuir, vol. 29, no. 49, pp. 15375–15385, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. B. Rossi, V. Venuti, F. D'Amico et al., “Toward an understanding of the thermosensitive behaviour of pH-responsive hydrogels based on cyclodextrins,” Soft Matter, vol. 11, no. 29, pp. 5862–5871, 2015. View at Publisher · View at Google Scholar
  31. S. Ruan, X. Cao, X. Cun et al., “Matrix metalloproteinase-sensitive size-shrinkable nanoparticles for deep tumor penetration and pH triggered doxorubicin release,” Biomaterials, vol. 60, pp. 100–110, 2015. View at Publisher · View at Google Scholar
  32. A. Wang, H. Gao, Y. Sun et al., “Temperature- and pH-responsive nanoparticles of biocompatible polyurethanes for doxorubicin delivery,” International Journal of Pharmaceutics, vol. 441, no. 1-2, pp. 30–39, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. A. Kawamura, Y. Hata, T. Miyata, and T. Uragami, “Synthesis of glucose-responsive bioconjugated gel particles using surfactant-free emulsion polymerization,” Colloids and Surfaces B: Biointerfaces, vol. 99, pp. 74–81, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. L. Ren, L. He, T. Sun et al., “Dual-responsive supramolecular hydrogels from water-soluble PEG-grafted copolymers and cyclodextrin,” Macromolecular Bioscience, vol. 9, no. 9, pp. 902–910, 2009. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. Qiu and K. Park, “Environment-sensitive hydrogels for drug delivery,” Advanced Drug Delivery Reviews, vol. 53, no. 3, pp. 321–339, 2001. View at Publisher · View at Google Scholar · View at Scopus
  36. B. P. Purcell, D. Lobb, M. B. Charati et al., “Injectable and bioresponsive hydrogels for on-demand matrix metalloproteinase inhibition,” Nature Materials, vol. 13, no. 6, pp. 653–661, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Flemming, “Drug delivery: non-invasive drug depot refill,” Nature Reviews Drug Discovery, vol. 13, no. 11, pp. 810–811, 2014. View at Publisher · View at Google Scholar · View at Scopus
  38. J. M. Anderson, A. Rodriguez, and D. T. Chang, “Foreign body reaction to biomaterials,” Seminars in Immunology, vol. 20, no. 2, pp. 86–100, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Londono and S. F. Badylak, “Biologic scaffolds for regenerative medicine: mechanisms of in vivo remodeling,” Annals of Biomedical Engineering, vol. 43, no. 3, pp. 577–592, 2015. View at Publisher · View at Google Scholar
  40. Z. Abdullah, T. Saric, H. Kashkar et al., “Serpin-6 expression protects embryonic stem cells from lysis by antigen-specific CTL,” The Journal of Immunology, vol. 178, no. 6, pp. 3390–3399, 2007. View at Publisher · View at Google Scholar · View at Scopus
  41. S. Bonde, K.-M. Chan, and N. Zavazava, “ES-cell derived hematopoietic cells induce transplantation tolerance,” PLoS ONE, vol. 3, no. 9, Article ID e3212, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Bonde and N. Zavazava, “Immunogenicity and engraftment of mouse embryonic stem cells in allogeneic recipients,” Stem Cells, vol. 24, no. 10, pp. 2192–2201, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. A. S. Boyd and K. J. Wood, “Variation in MHC expression between undifferentiated mouse ES cells and ES cell-derived insulin-producing cell clusters,” Transplantation, vol. 87, no. 9, pp. 1300–1304, 2009. View at Publisher · View at Google Scholar · View at Scopus
  44. L. Li, M. L. Baroja, A. Majumdar et al., “Human embryonic stem cells possess immune-privileged properties,” Stem Cells, vol. 22, no. 4, pp. 448–456, 2004. View at Publisher · View at Google Scholar · View at Scopus
  45. L. Tian, J. W. Catt, C. O'Neill, and N. J. C. King, “Expression of immunoglobulin superfamily cell adhesion molecules on murine embryonic stem cells,” Biology of Reproduction, vol. 57, no. 3, pp. 561–568, 1997. View at Publisher · View at Google Scholar · View at Scopus
  46. H.-F. Chen, C.-Y. Yu, M.-J. Chen et al., “Characteristic expression of major histocompatibility complex and immune privilege genes in human pluripotent stem cells and their derivatives,” Cell Transplantation, vol. 24, no. 5, pp. 845–864, 2015. View at Publisher · View at Google Scholar
  47. S. Kadereit and A. Trounson, “In vitro immunogenicity of undifferentiated pluripotent stem cells (PSC) and derived lineages,” Seminars in Immunopathology, vol. 33, no. 6, pp. 551–562, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. J. I. Pearl, L. S. Kean, M. M. Davis, and J. C. Wu, “Pluripotent stem cells: immune to the immune system?” Science Translational Medicine, vol. 4, no. 164, Article ID 164ps25, 2012. View at Publisher · View at Google Scholar
  49. B. Suárez-Álvarez, R. M. Rodriguez, V. Calvanese et al., “Epigenetic mechanisms regulate MHC and antigen processing molecules in human embryonic and induced pluripotent stem cells,” PLoS ONE, vol. 5, no. 4, Article ID e10192, 2010. View at Publisher · View at Google Scholar · View at Scopus
  50. F. Fändrich, X. Lin, G. X. Chai et al., “Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning,” Nature Medicine, vol. 8, no. 2, pp. 171–178, 2002. View at Publisher · View at Google Scholar · View at Scopus
  51. C. A. Koch, P. Geraldes, and J. L. Platt, “Immunosuppression by embryonic stem cells,” Stem Cells, vol. 26, no. 1, pp. 89–98, 2008. View at Publisher · View at Google Scholar · View at Scopus
  52. L. V. Schnabel, C. M. Abratte, J. C. Schimenti et al., “Induced pluripotent stem cells have similar immunogenic and more potent immunomodulatory properties compared with bone marrow-derived stromal cells in vitro,” Regenerative Medicine, vol. 9, no. 5, pp. 621–635, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. M. Drukker, H. Katchman, G. Katz et al., “Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells,” Stem Cells, vol. 24, no. 2, pp. 221–229, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. N. Yachimovich-Cohen, S. Even-Ram, Y. Shufaro, J. Rachmilewitz, and B. Reubinoff, “Human embryonic stem cells suppress T cell responses via arginase I-dependent mechanism,” The Journal of Immunology, vol. 184, no. 3, pp. 1300–1308, 2010. View at Publisher · View at Google Scholar · View at Scopus
  55. B. Imberti, F. Casiraghi, D. Cugini et al., “Embryonic stem cells, derived either after in vitro fertilization or nuclear transfer, prolong survival of semiallogeneic heart transplants,” Journal of Immunology, vol. 186, no. 7, pp. 4164–4174, 2011. View at Publisher · View at Google Scholar · View at Scopus
  56. M. Drukker, “Immunogenicity of embryonic stem cells and their progeny,” Methods in Enzymology, vol. 420, pp. 391–409, 2006. View at Google Scholar
  57. C. Ménard, A. A. Hagège, O. Agbulut et al., “Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: a preclinical study,” The Lancet, vol. 366, no. 9490, pp. 1005–1012, 2005. View at Publisher · View at Google Scholar · View at Scopus
  58. T. Kofidis, J. L. deBruin, M. Tanaka et al., “They are not stealthy in the heart: embryonic stem cells trigger cell infiltration, humoral and T-lymphocyte-based host immune response,” European Journal of Cardio-Thoracic Surgery, vol. 28, no. 3, pp. 461–466, 2005. View at Publisher · View at Google Scholar · View at Scopus
  59. J. Nussbaum, E. Minami, M. A. Laflamme et al., “Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response,” The FASEB Journal, vol. 21, no. 7, pp. 1345–1357, 2007. View at Publisher · View at Google Scholar
  60. R.-J. Swijnenburg, M. Tanaka, H. Vogel et al., “Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium,” Circulation, vol. 112, no. 9, supplement, pp. I166–I172, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. B. Imberti, M. Monti, and F. Casiraghi, “Pluripotent stem cells and tolerance induction in organ transplantation,” Current Opinion in Organ Transplantation, vol. 20, no. 1, pp. 86–93, 2015. View at Publisher · View at Google Scholar · View at Scopus
  62. B. Parekkadan and J. M. Milwid, “Mesenchymal stem cells as therapeutics,” Annual Review of Biomedical Engineering, vol. 12, pp. 87–117, 2010. View at Publisher · View at Google Scholar · View at Scopus
  63. H. Yagi, A. Soto-Gutierrez, B. Parekkadan et al., “Mesenchymal stem cells: mechanisms of immunomodulation and homing,” Cell Transplantation, vol. 19, no. 6-7, pp. 667–679, 2010. View at Publisher · View at Google Scholar · View at Scopus
  64. L. Fouillard, S. Francois, S. Bouchet, M. Bensidhoum, A. Elm'selmi, and A. Chapel, “Innovative cell therapy in the treatment of serious adverse events related to both chemo-radiotherapy protocol and acute myeloid leukemia syndrome: the infusion of mesenchymal stem cells post-treatment reduces hematopoietic toxicity and promotes hematopoietic reconstitution,” Current Pharmaceutical Biotechnology, vol. 14, no. 9, pp. 842–848, 2013. View at Google Scholar · View at Scopus
  65. H. M. Lazarus, O. N. Koc, S. M. Devine et al., “Cotransplantation of HLA-identical sibling culture-expanded mesenchymal stem cells and hematopoietic stem cells in hematologic malignancy patients,” Biology of Blood and Marrow Transplantation, vol. 11, no. 5, pp. 389–398, 2005. View at Publisher · View at Google Scholar · View at Scopus
  66. F. Casiraghi, N. Perico, and G. Remuzzi, “Mesenchymal stromal cells to promote solid organ transplantation tolerance,” Current Opinion in Organ Transplantation, vol. 18, no. 1, pp. 51–58, 2013. View at Publisher · View at Google Scholar · View at Scopus
  67. N. Perico, F. Casiraghi, M. Introna et al., “Autologous mesenchymal stromal cells and kidney transplantation: a pilot study of safety and clinical feasibility,” Clinical Journal of the American Society of Nephrology, vol. 6, no. 2, pp. 412–422, 2011. View at Publisher · View at Google Scholar · View at Scopus
  68. J. Y. Weng, X. Du, S. X. Geng et al., “Mesenchymal stem cell as salvage treatment for refractory chronic GVHD,” Bone Marrow Transplantation, vol. 45, no. 12, pp. 1732–1740, 2010. View at Publisher · View at Google Scholar · View at Scopus
  69. J. A. Plock, J. T. Schnider, W. Zhang et al., “Adipose- and bone marrow-derived mesenchymal stem cells prolong graft survival in vascularized composite allotransplantation,” Transplantation, vol. 99, no. 9, pp. 1765–1773, 2015. View at Publisher · View at Google Scholar
  70. C. Ballet, G. Roussey-Kesler, J.-T. Aubin et al., “Humoral and cellular responses to influenza vaccination in human recipients naturally tolerant to a kidney allograft,” American Journal of Transplantation, vol. 6, no. 11, pp. 2796–2801, 2006. View at Publisher · View at Google Scholar · View at Scopus
  71. G. W. McCaughan, D. G. Bowen, and P. Bertolino, “Operational tolerance in liver transplantation: shall we predict or promote?” Liver Transplantation, vol. 19, no. 9, pp. 933–936, 2013. View at Publisher · View at Google Scholar · View at Scopus
  72. T. Kawai, D. H. Sachs, M. Sykes, and A. B. Cosimi, “HLA-mismatched renal transplantation without maintenance immunosuppression,” The New England Journal of Medicine, vol. 368, no. 19, pp. 1850–1852, 2013. View at Publisher · View at Google Scholar · View at Scopus
  73. J. Leventhal, M. Abecassis, J. Miller et al., “Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation,” Science Translational Medicine, vol. 4, no. 124, Article ID 124ra28, 2012. View at Publisher · View at Google Scholar · View at Scopus
  74. J. D. Scandling, S. Busque, S. Dejbakhsh-Jones et al., “Tolerance and chimerism after renal and hematopoietic-cell transplantation,” The New England Journal of Medicine, vol. 358, no. 4, pp. 362–368, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. D. A. Leonard, C. L. Cetrulo, D. A. McGrouther, and D. H. Sachs, “Induction of tolerance of vascularized composite allografts,” Transplantation, vol. 95, no. 3, pp. 403–409, 2013. View at Publisher · View at Google Scholar · View at Scopus
  76. D. A. Leonard, J. M. Kurtz, C. Mallard et al., “Vascularized composite allograft tolerance across MHC barriers in a large animal model,” American Journal of Transplantation, vol. 14, no. 2, pp. 343–355, 2014. View at Publisher · View at Google Scholar · View at Scopus
  77. B. N. Brown and S. F. Badylak, “Extracellular matrix as an inductive scaffold for functional tissue reconstruction,” Translational Research, vol. 163, no. 4, pp. 268–285, 2014. View at Publisher · View at Google Scholar · View at Scopus
  78. M. van der Rest and R. Garrone, “Collagen family of proteins,” The FASEB Journal, vol. 5, no. 13, pp. 2814–2823, 1991. View at Google Scholar · View at Scopus
  79. M. Sundaramoorthy, M. Meiyappan, P. Todd, and B. G. Hudson, “Crystal structure of NC1 domains: structural basis for type IV collagen assembly in basement membranes,” Journal of Biological Chemistry, vol. 277, no. 34, pp. 31142–31153, 2002. View at Publisher · View at Google Scholar · View at Scopus
  80. H. L. Birch, C. T. Thorpe, and A. P. Rumian, “Specialisation of extracellular matrix for function in tendons and ligaments,” Muscles, Ligaments and Tendons Journal, vol. 3, no. 1, pp. 12–22, 2013. View at Publisher · View at Google Scholar · View at Scopus
  81. M. L. Ponce, M. Nomizu, M. C. Delgado et al., “Identification of endothelial cell binding sites on the laminin γ1 chain,” Circulation Research, vol. 84, no. 6, pp. 688–694, 1999. View at Publisher · View at Google Scholar · View at Scopus
  82. R. V. Iozzo, I. R. Cohen, S. Grassel, and A. D. Murdoch, “The biology of perlecan: the multifaceted heparan sulphate proteoglycan of basement membranes and pericellular matrices,” Biochemical Journal, vol. 302, part 3, pp. 625–639, 1994. View at Publisher · View at Google Scholar · View at Scopus
  83. R. V. Iozzo and A. D. Murdoch, “Proteoglycans of the extracellular environment: clues from the gene and protein side offer novel perspectives in molecular diversity and function,” The FASEB Journal, vol. 10, no. 5, pp. 598–614, 1996. View at Google Scholar · View at Scopus
  84. A. Kanematsu, A. Marui, S. Yamamoto et al., “Type I collagen can function as a reservoir of basic fibroblast growth factor,” Journal of Controlled Release, vol. 99, no. 2, pp. 281–292, 2004. View at Publisher · View at Google Scholar · View at Scopus
  85. J. Li, Y.-P. Zhang, and R. S. Kirsner, “Angiogenesis in wound repair: angiogenic growth factors and the extracellular matrix,” Microscopy Research and Technique, vol. 60, no. 1, pp. 107–114, 2003. View at Publisher · View at Google Scholar · View at Scopus
  86. I. Matsuo and C. Kimura-Yoshida, “Extracellular distribution of diffusible growth factors controlled by heparan sulfate proteoglycans during mammalian embryogenesis,” Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 369, no. 1657, 2014. View at Publisher · View at Google Scholar · View at Scopus
  87. D. J. Tschumperlin, “Matrix, mesenchyme, and mechanotransduction,” Annals of the American Thoracic Society, vol. 12, supplement 1, pp. S24–S29, 2015. View at Google Scholar
  88. M. J. Bissell and J. Aggeler, “Dynamic reciprocity: how do extracellular matrix and hormones direct gene expression?” Progress in Clinical and Biological Research, vol. 249, pp. 251–262, 1987. View at Google Scholar · View at Scopus
  89. B. N. Brown, J. E. Valentin, A. M. Stewart-Akers, G. P. McCabe, and S. F. Badylak, “Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component,” Biomaterials, vol. 30, no. 8, pp. 1482–1491, 2009. View at Publisher · View at Google Scholar · View at Scopus
  90. T. J. Keane, R. Londono, N. J. Turner, and S. F. Badylak, “Consequences of ineffective decellularization of biologic scaffolds on the host response,” Biomaterials, vol. 33, no. 6, pp. 1771–1781, 2012. View at Publisher · View at Google Scholar · View at Scopus
  91. P. M. Crapo, T. W. Gilbert, and S. F. Badylak, “An overview of tissue and whole organ decellularization processes,” Biomaterials, vol. 32, no. 12, pp. 3233–3243, 2011. View at Publisher · View at Google Scholar · View at Scopus
  92. J. L. Butterfield, “440 consecutive immediate, implant-based, single-surgeon breast reconstructions in 281 patients: a comparison of early outcomes and costs between SurgiMend fetal bovine and AlloDerm human cadaveric acellular dermal matrices,” Plastic and Reconstructive Surgery, vol. 131, no. 5, pp. 940–951, 2013. View at Publisher · View at Google Scholar · View at Scopus
  93. N. A. Kissane and K. M. F. Itani, “A decade of ventral incisional hernia repairs with biologic acellular dermal matrix: what have we learned?” Plastic and Reconstructive Surgery, vol. 130, no. 5, supplement 2, pp. 194S–202S, 2012. View at Google Scholar · View at Scopus
  94. D. D. Leventhal and E. A. Pribitkin, “Static facial suspension with surgisis ES (enhanced strength) sling,” Laryngoscope, vol. 118, no. 1, pp. 20–23, 2008. View at Publisher · View at Google Scholar · View at Scopus
  95. B. M. Sicari, J. Peter Rubin, C. L. Dearth et al., “An acellular biologic scaffold promotes skeletal muscle formation in mice and humans with volumetric muscle loss,” Science Translational Medicine, vol. 6, no. 234, Article ID 234ra58, 2014. View at Publisher · View at Google Scholar · View at Scopus
  96. S. F. Badylak, “Decellularized allogeneic and xenogeneic tissue as a bioscaffold for regenerative medicine: factors that influence the host response,” Annals of Biomedical Engineering, vol. 42, no. 7, pp. 1517–1527, 2014. View at Publisher · View at Google Scholar · View at Scopus
  97. J. E. Valentin, A. M. Stewart-Akers, T. W. Gilbert, and S. F. Badylak, “Macrophage participation in the degradation and remodeling of extracellular matrix scaffolds,” Tissue Engineering—Part A, vol. 15, no. 7, pp. 1687–1694, 2009. View at Publisher · View at Google Scholar · View at Scopus
  98. T. D. Johnson, R. L. Braden, and K. L. Christman, “Injectable ECM scaffolds for cardiac repair,” Methods in Molecular Biology, vol. 1181, pp. 109–120, 2014. View at Publisher · View at Google Scholar · View at Scopus
  99. C. J. Medberry, P. M. Crapo, B. F. Siu et al., “Hydrogels derived from central nervous system extracellular matrix,” Biomaterials, vol. 34, no. 4, pp. 1033–1040, 2013. View at Publisher · View at Google Scholar · View at Scopus
  100. M. J. Sawkins, W. Bowen, P. Dhadda et al., “Hydrogels derived from demineralized and decellularized bone extracellular matrix,” Acta Biomaterialia, vol. 9, no. 8, pp. 7865–7873, 2013. View at Publisher · View at Google Scholar · View at Scopus
  101. J. L. Ungerleider, T. D. Johnson, N. Rao, and K. L. Christman, “Fabrication and characterization of injectable hydrogels derived from decellularized skeletal and cardiac muscle,” Methods, vol. 84, pp. 53–59, 2015. View at Publisher · View at Google Scholar
  102. D. O. Freytes, R. M. Stoner, and S. F. Badylak, “Uniaxial and biaxial properties of terminally sterilized porcine urinary bladder matrix scaffolds,” Journal of Biomedical Materials Research Part B: Applied Biomaterials, vol. 84, no. 2, pp. 408–414, 2008. View at Publisher · View at Google Scholar · View at Scopus
  103. G. A. Gholami, A. Saberi, M. Kadkhodazadeh, R. Amid, and D. Karami, “Comparison of the clinical outcomes of connective tissue and acellular dermal matrix in combination with double papillary flap for root coverage: a 6-month trial,” Dental Research Journal, vol. 10, no. 4, pp. 506–513, 2013. View at Google Scholar
  104. J. Lecheminant and C. Field, “Porcine urinary bladder matrix: a retrospective study and establishment of protocol,” Journal of Wound Care, vol. 21, no. 10, pp. 476–482, 2012. View at Publisher · View at Google Scholar
  105. S. F. Badylak, T. Hoppo, A. Nieponice, T. W. Gilbert, J. M. Davison, and B. A. Jobe, “Esophageal preservation in five male patients after endoscopic inner-layer circumferential resection in the setting of superficial cancer: a regenerative medicine approach with a biologic scaffold,” Tissue Engineering Part: A, vol. 17, no. 11-12, pp. 1643–1650, 2011. View at Publisher · View at Google Scholar · View at Scopus
  106. S. A. Alpert, E. Y. Cheng, W. E. Kaplan, W. T. Snodgrass, D. T. Wilcox, and B. P. Kropp, “Bladder neck fistula after the complete primary repair of exstrophy: a multi-institutional experience,” Journal of Urology, vol. 174, no. 4, part 2, pp. 1687–1689, 2005. View at Publisher · View at Google Scholar
  107. J. M. Ladowski and J. S. Ladowski, “Retrospective analysis of bovine pericardium (Vascu-Guard) for patch closure in carotid endarterectomies,” Annals of Vascular Surgery, vol. 25, no. 5, pp. 646–650, 2011. View at Publisher · View at Google Scholar
  108. J. R. Cintron, H. Abcarian, V. Chaudhry et al., “Treatment of fistula-in-ano using a porcine small intestinal submucosa anal fistula plug,” Techniques in Coloproctology, vol. 17, no. 2, pp. 187–191, 2013. View at Publisher · View at Google Scholar
  109. F. G. Scholl, M. M. Boucek, K. C. Chan, L. Valdes-Cruz, and R. Perryman, “Preliminary experience with cardiac reconstruction using decellularized porcine extracellular matrix scaffold: human applications in congenital heart disease,” World Journal for Pediatric and Congenital Heart Surgery, vol. 1, no. 1, pp. 132–136, 2010. View at Publisher · View at Google Scholar
  110. K. A. Daly, S. Liu, V. Agrawal et al., “The host response to endotoxin-contaminated dermal matrix,” Tissue Engineering Part A, vol. 18, no. 11-12, pp. 1293–1303, 2012. View at Publisher · View at Google Scholar · View at Scopus
  111. F. Ambrosio, S. L. Wolf, A. Delitto et al., “The emerging relationship between regenerative medicine and physical therapeutics,” Physical Therapy, vol. 90, no. 12, pp. 1807–1814, 2010. View at Publisher · View at Google Scholar · View at Scopus
  112. S. M. Slack, J. L. Bohnert, and T. A. Horbett, “The effects of surface chemistry and coagulation factors on fibrinogen adsorption from plasma,” Annals of the New York Academy of Sciences, vol. 516, pp. 223–243, 1987. View at Publisher · View at Google Scholar · View at Scopus
  113. L. E. Carey, C. L. Dearth, S. A. Johnson et al., “In vivo degradation of 14C-labeled porcine dermis biologic scaffold,” Biomaterials, vol. 35, no. 29, pp. 8297–8304, 2014. View at Publisher · View at Google Scholar · View at Scopus
  114. T. W. Gilbert, A. M. Stewart-Akers, A. Simmons-Byrd, and S. F. Badylak, “Degradation and remodeling of small intestinal submucosa in canine Achilles tendon repair,” The Journal of Bone & Joint Surgery—American Volume, vol. 89, no. 3, pp. 621–630, 2007. View at Publisher · View at Google Scholar · View at Scopus
  115. G. E. Davis, K. J. Bayless, M. J. Davis, and G. A. Meininger, “Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules,” The American Journal of Pathology, vol. 156, no. 5, pp. 1489–1498, 2000. View at Publisher · View at Google Scholar · View at Scopus
  116. S. Ricard-Blum and L. Ballut, “Matricryptins derived from collagens and proteoglycans,” Frontiers in Bioscience, vol. 16, no. 2, pp. 674–697, 2011. View at Publisher · View at Google Scholar · View at Scopus
  117. S. Collaud, T. Warloe, O. Jordan, R. Gurny, and N. Lange, “Clinical evaluation of bioadhesive hydrogels for topical delivery of hexylaminolevulinate to Barrett's esophagus,” Journal of Controlled Release, vol. 123, no. 3, pp. 203–210, 2007. View at Publisher · View at Google Scholar · View at Scopus
  118. J. K. Kim, H. J. Kim, J.-Y. Chung, J.-H. Lee, S.-B. Young, and Y.-H. Kim, “Natural and synthetic biomaterials for controlled drug delivery,” Archives of Pharmacal Research, vol. 37, no. 1, pp. 60–68, 2014. View at Publisher · View at Google Scholar · View at Scopus
  119. J. A. DeQuach, J. E. Lin, C. Cam et al., “Injectable skeletal muscle matrix hydrogel promotes neovascularization and muscle cell infiltration in a hindlimb ischemia model,” European Cells and Materials, vol. 23, pp. 400–412, 2012. View at Google Scholar · View at Scopus
  120. D. M. Faulk, R. Londono, M. T. Wolf et al., “ECM hydrogel coating mitigates the chronic inflammatory response to polypropylene mesh,” Biomaterials, vol. 35, no. 30, pp. 8585–8595, 2014. View at Publisher · View at Google Scholar · View at Scopus
  121. T. D. Johnson and K. L. Christman, “Injectable hydrogel therapies and their delivery strategies for treating myocardial infarction,” Expert Opinion on Drug Delivery, vol. 10, no. 1, pp. 59–72, 2013. View at Publisher · View at Google Scholar · View at Scopus
  122. M. T. Wolf, K. A. Daly, E. P. Brennan-Pierce et al., “A hydrogel derived from decellularized dermal extracellular matrix,” Biomaterials, vol. 33, no. 29, pp. 7028–7038, 2012. View at Publisher · View at Google Scholar · View at Scopus
  123. S. B. Seif-Naraghi, D. Horn, P. J. Schup-Magoffin, and K. L. Christman, “Injectable extracellular matrix derived hydrogel provides a platform for enhanced retention and delivery of a heparin-binding growth factor,” Acta Biomaterialia, vol. 8, no. 10, pp. 3695–3703, 2012. View at Publisher · View at Google Scholar · View at Scopus
  124. D. O. Freytes, J. Martin, S. S. Velankar, A. S. Lee, and S. F. Badylak, “Preparation and rheological characterization of a gel form of the porcine urinary bladder matrix,” Biomaterials, vol. 29, no. 11, pp. 1630–1637, 2008. View at Publisher · View at Google Scholar · View at Scopus
  125. Y.-R. Kuo, S. Goto, H.-S. Shih et al., “Mesenchymal stem cells prolong composite tissue allotransplant survival in a swine model,” Transplantation, vol. 87, no. 12, pp. 1769–1777, 2009. View at Publisher · View at Google Scholar · View at Scopus
  126. J. A. Plock, J. T. Schnider, R. Schweizer, and V. S. Gorantla, “Are cultured mesenchymal stromal cells an option for immunomodulation in transplantation?” Frontiers in Immunology, vol. 4, article 41, 2013. View at Publisher · View at Google Scholar · View at Scopus
  127. S. Schlosser, C. Dennler, R. Schweizer et al., “Paracrine effects of mesenchymal stem cells enhance vascular regeneration in ischemic murine skin,” Microvascular Research, vol. 83, no. 3, pp. 267–275, 2012. View at Publisher · View at Google Scholar · View at Scopus
  128. R. H. Lee, A. A. Pulin, M. J. Seo et al., “Intravenous hMSCs improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6,” Cell Stem Cell, vol. 5, no. 1, pp. 54–63, 2009. View at Publisher · View at Google Scholar · View at Scopus
  129. S. Schneeberger, V. S. Gorantla, G. Brandacher et al., “Upper-extremity transplantation using a cell-based protocol to minimize immunosuppression,” Annals of Surgery, vol. 257, no. 2, pp. 345–351, 2013. View at Publisher · View at Google Scholar
  130. B. G. Ballios, M. J. Cooke, L. Donaldson et al., “A hyaluronan-based injectable hydrogel improves the survival and integration of stem cell progeny following transplantation,” Stem Cell Reports, vol. 4, no. 6, pp. 1031–1045, 2015. View at Publisher · View at Google Scholar
  131. S. A. Fisher, R. Y. Tam, and M. S. Shoichet, “Tissue mimetics: engineered hydrogel matrices provide biomimetic environments for cell growth,” Tissue Engineering Part A, vol. 20, no. 5-6, pp. 895–898, 2014. View at Publisher · View at Google Scholar · View at Scopus
  132. J. Cortiella, J. Niles, A. Cantu et al., “Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation,” Tissue Engineering Part A, vol. 16, no. 8, pp. 2565–2580, 2010. View at Publisher · View at Google Scholar · View at Scopus
  133. S. Khalifian, K. A. Sarhane, M. Tammia et al., “Stem cell-based approaches to improve nerve regeneration: potential implications for reconstructive transplantation?” Archivum Immunologiae et Therapiae Experimentalis, vol. 63, no. 1, pp. 15–30, 2015. View at Publisher · View at Google Scholar · View at Scopus
  134. R. Londono, B. A. Jobe, T. Hoppo, and S. F. Badylak, “Esophagus and regenerative medicine,” World Journal of Gastroenterology, vol. 18, no. 47, pp. 6894–6899, 2012. View at Publisher · View at Google Scholar · View at Scopus
  135. A. Nieponice, F. F. Ciotola, F. Nachman et al., “Patch esophagoplasty: esophageal reconstruction using biologic scaffolds,” Annals of Thoracic Surgery, vol. 97, no. 1, pp. 283–288, 2014. View at Publisher · View at Google Scholar · View at Scopus
  136. R. S. Sutherland, L. S. Baskin, S. W. Hayward, and G. R. Cunha, “Regeneration of bladder urothelium, smooth muscle, blood vessels and nerves into an acellular tissue matrix,” Journal of Urology, vol. 156, no. 2, part 2, pp. 571–577, 1996. View at Publisher · View at Google Scholar · View at Scopus
  137. J. D. Wood, A. Simmons-Byrd, A. R. Spievack, and S. F. Badylak, “Use of a particulate extracellular matrix bioscaffold for treatment of acquired urinary incontinence in dogs,” Journal of the American Veterinary Medical Association, vol. 226, no. 7, pp. 1095–1097, 2005. View at Publisher · View at Google Scholar · View at Scopus
  138. J. P. Iannotti, M. J. Codsi, Y. W. Kwon, K. Derwin, J. Ciccone, and J. J. Brems, “Porcine small intestine submucosa augmentation of surgical repair of chronic two-tendon rotator cuff tears: a randomized, controlled trial,” Journal of Bone and Joint Surgery Series: A, vol. 88, no. 6, pp. 1238–1244, 2006. View at Publisher · View at Google Scholar · View at Scopus
  139. T. Zantop, T. W. Gilbert, M. C. Yoder, and S. F. Badylak, “Extracellular matrix scaffolds are repopulated by bone marrow-derived cells in a mouse model of Achilles tendon reconstruction,” Journal of Orthopaedic Research, vol. 24, no. 6, pp. 1299–1309, 2006. View at Publisher · View at Google Scholar · View at Scopus
  140. V. Agrawal, B. N. Brown, A. J. Beattie, T. W. Gilbert, and S. F. Badylak, “Evidence of innervation following extracellular matrix scaffold-mediated remodelling of muscular tissues,” Journal of Tissue Engineering and Regenerative Medicine, vol. 3, no. 8, pp. 590–600, 2009. View at Publisher · View at Google Scholar · View at Scopus
  141. J. E. Valentin, N. J. Turner, T. W. Gilbert, and S. F. Badylak, “Functional skeletal muscle formation with a biologic scaffold,” Biomaterials, vol. 31, no. 29, pp. 7475–7484, 2010. View at Publisher · View at Google Scholar · View at Scopus
  142. S. Badylak, T. Gilbert, and J. Myers-Irvin, “The extracellular matrix as a biologic scaffold for tissue engineering,” Tissue Engineering, pp. 121–143, 2008. View at Publisher · View at Google Scholar · View at Scopus
  143. E. Bible, F. Dell'Acqua, B. Solanky et al., “Non-invasive imaging of transplanted human neural stem cells and ECM scaffold remodeling in the stroke-damaged rat brain by (19)F- and diffusion-MRI,” Biomaterials, vol. 33, no. 10, pp. 2858–2871, 2012. View at Publisher · View at Google Scholar · View at Scopus
  144. L. Zhang, F. Zhang, Z. Weng et al., “Effect of an inductive hydrogel composed of urinary bladder matrix upon functional recovery following traumatic brain injury,” Tissue Engineering. Part A, vol. 19, no. 17-18, pp. 1909–1918, 2013. View at Publisher · View at Google Scholar · View at Scopus
  145. R. A. Allen, L. M. Seltz, H. Jiang et al., “Adrenal extracellular matrix scaffolds support adrenocortical cell proliferation and function in vitro,” Tissue Engineering Part A, vol. 16, no. 11, pp. 3363–3374, 2010. View at Publisher · View at Google Scholar · View at Scopus
  146. T. L. Sellaro, A. Ranade, D. M. Faulk et al., “Maintenance of human hepatocyte function in vitro by liver-derived extracellular matrix gels,” Tissue Engineering Part: A, vol. 16, no. 3, pp. 1075–1082, 2010. View at Publisher · View at Google Scholar · View at Scopus
  147. T. L. Sellaro, A. K. Ravindra, D. B. Stolz, and S. F. Badylak, “Maintenance of hepatic sinusoidal endothelial cell phenotype in vitro using organ-specific extracellular matrix scaffolds,” Tissue Engineering, vol. 13, no. 9, pp. 2301–2310, 2007. View at Publisher · View at Google Scholar · View at Scopus
  148. J. M. Singelyn, P. Sundaramurthy, T. D. Johnson et al., “Catheter-deliverable hydrogel derived from decellularized ventricular extracellular matrix increases endogenous cardiomyocytes and preserves cardiac function post-myocardial infarction,” Journal of the American College of Cardiology, vol. 59, no. 8, pp. 751–763, 2012. View at Publisher · View at Google Scholar · View at Scopus
  149. P. M. Crapo, C. J. Medberry, J. E. Reing et al., “Biologic scaffolds composed of central nervous system extracellular matrix,” Biomaterials, vol. 33, no. 13, pp. 3539–3547, 2012. View at Publisher · View at Google Scholar · View at Scopus
  150. M. Szynkaruk, S. W. P. Kemp, M. D. Wood, T. Gordon, and G. H. Borschel, “Experimental and clinical evidence for use of decellularized nerve allografts in peripheral nerve gap reconstruction,” Tissue Engineering. Part B: Reviews, vol. 19, no. 1, pp. 83–96, 2013. View at Publisher · View at Google Scholar · View at Scopus
  151. A. V. Boruch, A. Nieponice, I. R. Qureshi, T. W. Gilbert, and S. F. Badylak, “Constructive remodeling of biologic scaffolds is dependent on early exposure to physiologic bladder filling in a canine partial cystectomy model,” Journal of Surgical Research, vol. 161, no. 2, pp. 217–225, 2010. View at Publisher · View at Google Scholar · View at Scopus
  152. N. J. Turner, A. J. Yates, D. J. Weber et al., “Xenogeneic extracellular matrix as an inductive scaffold for regeneration of a functioning musculotendinous junction,” Tissue Engineering Part: A, vol. 16, no. 11, pp. 3309–3317, 2010. View at Publisher · View at Google Scholar · View at Scopus
  153. T. W. Gilbert, D. B. Stolz, F. Biancaniello, A. Simmons-Byrd, and S. F. Badylak, “Production and characterization of ECM powder: implications for tissue engineering applications,” Biomaterials, vol. 26, no. 12, pp. 1431–1435, 2005. View at Publisher · View at Google Scholar · View at Scopus
  154. S. Mazzitelli, G. Luca, F. Mancuso et al., “Production and characterization of engineered alginate-based microparticles containing ECM powder for cell/tissue engineering applications,” Acta Biomaterialia, vol. 7, no. 3, pp. 1050–1062, 2011. View at Publisher · View at Google Scholar · View at Scopus
  155. J. De Kock, L. Ceelen, W. De Spiegelaere et al., “Simple and quick method for whole-liver decellularization: a novel in vitro three-dimensional bioengineering tool?” Archives of Toxicology, vol. 85, no. 6, pp. 607–612, 2011. View at Publisher · View at Google Scholar · View at Scopus
  156. M. He and A. Callanan, “Comparison of methods for whole-organ decellularization in tissue engineering of bioartificial organs,” Tissue Engineering. Part B. Reviews, vol. 19, no. 3, pp. 194–208, 2013. View at Publisher · View at Google Scholar · View at Scopus
  157. N. T. Remlinger, P. D. Wearden, and T. W. Gilbert, “Procedure for decellularization of porcine heart by retrograde coronary perfusion,” Journal of Visualized Experiments, no. 70, Article ID e50059, 2012. View at Google Scholar · View at Scopus
  158. D. C. Sullivan, S.-H. Mirmalek-Sani, D. B. Deegan et al., “Decellularization methods of porcine kidneys for whole organ engineering using a high-throughput system,” Biomaterials, vol. 33, no. 31, pp. 7756–7764, 2012. View at Publisher · View at Google Scholar · View at Scopus
  159. A. Weymann, N. P. Patil, A. Sabashnikov et al., “Perfusion-decellularization of porcine lung and trachea for respiratory bioengineering,” Artificial Organs, 2015. View at Publisher · View at Google Scholar
  160. J. Qu, R. M. Van Hogezand, C. Zhao, B. J. Kuo, and B. T. Carlsen, “Decellularization of a fasciocutaneous flap for use as a perfusable scaffold,” Annals of Plastic Surgery, vol. 75, no. 1, pp. 112–116, 2015. View at Publisher · View at Google Scholar · View at Scopus
  161. S. Farnebo, C. Y. L. Woon, J. A. Bronstein et al., “Decellularized tendon-bone composite grafts for extremity reconstruction: an experimental study,” Plastic and Reconstructive Surgery, vol. 133, no. 1, pp. 79–89, 2014. View at Publisher · View at Google Scholar · View at Scopus
  162. L. Wang, J. A. Johnson, D. W. Chang, and Q. Zhang, “Decellularized musculofascial extracellular matrix for tissue engineering,” Biomaterials, vol. 34, no. 11, pp. 2641–2654, 2013. View at Publisher · View at Google Scholar · View at Scopus
  163. B. J. Jank, L. Xiong, P. T. Moser et al., “Engineered composite tissue as a bioartificial limb graft,” Biomaterials, vol. 61, pp. 246–256, 2015. View at Publisher · View at Google Scholar
  164. G. Brandacher, V. S. Gorantla, and W. P. A. Lee, “Hand allotransplantation,” Seminars in Plastic Surgery, vol. 24, no. 1, pp. 11–17, 2010. View at Publisher · View at Google Scholar · View at Scopus
  165. T. D. Johnson, J. A. Dequach, R. Gaetani et al., “Human versus porcine tissue sourcing for an injectable myocardial matrix hydrogel,” Biomaterials Science, vol. 2, no. 5, Article ID 60283D, pp. 735–744, 2014. View at Publisher · View at Google Scholar · View at Scopus
  166. S. F. Badylak, “The extracellular matrix as a scaffold for tissue reconstruction,” Seminars in Cell and Developmental Biology, vol. 13, no. 5, pp. 377–383, 2002. View at Publisher · View at Google Scholar · View at Scopus
  167. S. F. Badylak and R. M. Nerem, “Progress in tissue engineering and regenerative medicine,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 8, pp. 3285–3286, 2010. View at Publisher · View at Google Scholar · View at Scopus
  168. J. A. Plock, J. T. Schnider, M. G. Solari, X. X. Zheng, and V. S. Gorantla, “Perspectives on the use of mesenchymal stem cells in vascularized composite allotransplantation,” Frontiers in Immunology, vol. 4, article 175, 2013. View at Publisher · View at Google Scholar · View at Scopus